MHC Class II molecules are integral to the adaptive immune response, serving as specialised antigen-presenting proteins on the surface of professional antigen-presenting cells. They bind peptide ...
Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...
A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a ...
– Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development – – Cartography to receive upfront, ...
A new study led by UCL researchers suggests that making cancer cells more visible to the immune system could broaden the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results